Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates
- PMID: 1910006
- PMCID: PMC258922
- DOI: 10.1128/iai.59.10.3566-3573.1991
Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates
Abstract
The 12 types of meningococcal lipopolysaccharide (LPS) (immunotypes) contain immunotype-specific and cross-reactive epitopes situated on the oligosaccharide part of the LPS molecules. To identify useful cross-reactive epitopes and to determine minimal oligosaccharide structures required for the induction of an immune response against the most prevalent immunotypes, L1, L2, and L3,7,9, synthetic as well as native LPS-derived oligosaccharides were conjugated with tetanus toxoid. L3,7,9 phosphoethanolamine (PEA) group-containing oligosaccharide-tetanus toxoid conjugates evoked high immunoglobulin G (IgG) antibody levels in rabbits which were detected by an L2-, L3,7,9-, and, depending on the antiserum, L1-specific enzyme-linked immunosorbent assay (ELISA). Inhibition studies revealed that an identical antibody population was detected by L1 and L3,7,9 ELISA, indicating a similar tertiary structure of the inner core oligosaccharide of these two immunotypes. These antibodies recognize PEA group-containing epitopes present on the L1 and L3,7,9 LPS. An L2 PEA group-containing oligosaccharide-tetanus toxoid conjugate elicited L2- and L3,7,9-specific IgG antibodies, but in contrast with the L3,7,9 conjugates, no L1-specific IgG antibodies were evoked. These results indicate that L1 and L2 LPS do not contain cross-reactive epitopes, whereas both L2 and L3,7,9 LPS and L1 and L3,7,9 LPS possess common determinants. Three linear oligosaccharides and one branched oligosaccharide, representing partial structures of the inner core oligosacchardes of meningococcal LPS, were synthesized. Only the branched synthetic oligosaccharide-containing conjugate was able to induce and L1- and L3,7,9-specific immune response, whereas the linear oligosaccharide-protein conjugates evoked L2-specific immune responses. The branched oligosaccharide (beta-D-Glcp(1----4)-[L-alpha-D-Hepp(1----3)]-L-alpha-D-Hepp ) is therefore considered a minimal structure required for the induction of an immune response against L1 and L3,7,9 LPS and part of a cross-reactive epitope between these two immunotypes. For L2-specific immune responses, oligosaccharide structures terminating in beta-D-Glcp(1----4), alpha-D-GlcNAcp(1----2), or L-alpha-D-Hepp(1----5) are needed. The results suggest that it is possible to prepare an oligosaccharide structure with the ability to evoke an immune response against L1, L2, and L3,7,9 LPS. A feasible structure for such a "hybrid" oligosaccharide is discussed.
Similar articles
-
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Microbiol Rev. 1993 Mar;57(1):34-49. doi: 10.1128/mr.57.1.34-49.1993. Microbiol Rev. 1993. PMID: 8464406 Free PMC article. Review.
-
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.Infect Immun. 1991 Mar;59(3):843-51. doi: 10.1128/iai.59.3.843-851.1991. Infect Immun. 1991. PMID: 1900063 Free PMC article.
-
Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.Infect Immun. 1993 Jan;61(1):187-96. doi: 10.1128/iai.61.1.187-196.1993. Infect Immun. 1993. PMID: 8418041 Free PMC article.
-
The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies.Mol Immunol. 1991 Nov;28(11):1193-200. doi: 10.1016/0161-5890(91)90005-5. Mol Immunol. 1991. PMID: 1720502
-
Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide.Int J Med Microbiol. 2007 Sep;297(5):321-40. doi: 10.1016/j.ijmm.2007.04.002. Epub 2007 Jun 1. Int J Med Microbiol. 2007. PMID: 17544324 Review.
Cited by
-
Total Synthesis of a Pentasaccharide O-Glycan from Acinetobacter baumannii.European J Org Chem. 2022 Dec 19;2022(47):e202201261. doi: 10.1002/ejoc.202201261. Epub 2022 Dec 16. European J Org Chem. 2022. PMID: 36876192 Free PMC article.
-
Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis.Infect Immun. 2002 Mar;70(3):1293-300. doi: 10.1128/IAI.70.3.1293-1300.2002. Infect Immun. 2002. PMID: 11854213 Free PMC article.
-
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Microbiol Rev. 1993 Mar;57(1):34-49. doi: 10.1128/mr.57.1.34-49.1993. Microbiol Rev. 1993. PMID: 8464406 Free PMC article. Review.
-
Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis.J Bacteriol. 1996 Dec;178(23):6677-84. doi: 10.1128/jb.178.23.6677-6684.1996. J Bacteriol. 1996. PMID: 8955282 Free PMC article.
-
Comparative analysis of two meningococcal immunotyping monoclonal antibodies by resonant mirror biosensor and antibody gene sequencing.Clin Diagn Lab Immunol. 1999 Nov;6(6):838-43. doi: 10.1128/CDLI.6.6.838-843.1999. Clin Diagn Lab Immunol. 1999. PMID: 10548573 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources